Petra M. C. Callenbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Petra M. C. Callenbach has a total of 256 co-authors. Here are the top co-authors by number of shared publications:
Oebele F. Brouwer
Departments of Neurology University Medical Center Groningen University of Groningen Groningen the Netherlands
12 shared publications- Oebele F. Brouwer
Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
7 shared publications Ada T. Geerts
Neurology, Erasmus Medical Center, Rotterdam, Netherlands
6 shared publicationsHans Stroink
5 shared publicationsWillem Frans M. Arts
5 shared publicationsArmin Heils
4 shared publications
Latest Publications
- 26 October 2022
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 35 (9) , 2429-2431
The diagnostic value of urine microscopy: a comparison of nephrologist- versus laboratory-based interpretation
- 26 October 2022
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 35 (9) , 2429-2431
The diagnostic value of urine microscopy: a comparison of nephrologist- versus laboratory-based interpretation
- Open Access
- 1 May 2021
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 32, 128-135
Changes in empowerment and anxiety of patients and parents during genetic counselling for epilepsy
- 1 May 2021
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 32, 128-135
Open AccessChanges in empowerment and anxiety of patients and parents during genetic counselling for epilepsy
- 28 August 2019
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 21 (2) , 217-222
The diagnostic value of duplex ultrasound in detecting the presence and location of a stenosis in an autologous arteriovenous fistula
Objective: To determine the value of duplex ultrasound in the detection of significant (⩾50%) stenosis and the location of the stenosis in arteriovenous fistula, compared to angiography. Methods: Patients who underwent construction of an autologous arteriovenous fistula between January 2007 and December 2013 in Treant Care Group, hospital location Emmen, were included in this study. In all patients with a significantly decreased blood flow (flow <400 mL/min and/or ⩾20% decrease) measured by Transonic flowmeter before December 2016, duplex ultrasound was performed. Concordance between duplex ultrasound and angiography was analysed in all patients with a haemodynamically significant stenosis detected by duplex ultrasound. Results: In all, 63 patients had a significant decrease in blood flow leading to duplex ultrasound. In 51 (80.9%) of the 63 duplex ultrasound, a haemodynamically significant stenosis was detected. In 45 (88.2%) of these, angiography was performed, all confirming the presence of significant stenosis. In eight patients, no angiography was performed (sufficient residual blood flow (n = 7), death (n = 1)). Most stenoses were located in the venous outflow tract (75.6%). In 95.6%, a venous approach was possible during angiography. After intervention, a significant increase in blood flow was observed (from 530 mL/min to 910 mL/min (p < 0.001)). Conclusion: We show that duplex ultrasound is likely reliable to ascertain the presence of arteriovenous fistula stenosis in addition to flow criteria. Also, it provides important information to select the most effective and safe approach for cannulation. Duplex ultrasound may reduce costs and burden of diagnosing stenoses.
- 28 August 2019
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 21 (2) , 217-222
The diagnostic value of duplex ultrasound in detecting the presence and location of a stenosis in an autologous arteriovenous fistula
Objective: To determine the value of duplex ultrasound in the detection of significant (⩾50%) stenosis and the location of the stenosis in arteriovenous fistula, compared to angiography. Methods: Patients who underwent construction of an autologous arteriovenous fistula between January 2007 and December 2013 in Treant Care Group, hospital location Emmen, were included in this study. In all patients with a significantly decreased blood flow (flow <400 mL/min and/or ⩾20% decrease) measured by Transonic flowmeter before December 2016, duplex ultrasound was performed. Concordance between duplex ultrasound and angiography was analysed in all patients with a haemodynamically significant stenosis detected by duplex ultrasound. Results: In all, 63 patients had a significant decrease in blood flow leading to duplex ultrasound. In 51 (80.9%) of the 63 duplex ultrasound, a haemodynamically significant stenosis was detected. In 45 (88.2%) of these, angiography was performed, all confirming the presence of significant stenosis. In eight patients, no angiography was performed (sufficient residual blood flow (n = 7), death (n = 1)). Most stenoses were located in the venous outflow tract (75.6%). In 95.6%, a venous approach was possible during angiography. After intervention, a significant increase in blood flow was observed (from 530 mL/min to 910 mL/min (p < 0.001)). Conclusion: We show that duplex ultrasound is likely reliable to ascertain the presence of arteriovenous fistula stenosis in addition to flow criteria. Also, it provides important information to select the most effective and safe approach for cannulation. Duplex ultrasound may reduce costs and burden of diagnosing stenoses.
- 1 July 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 69, 298-303
Prevalence of sleep disturbances in people with epilepsy and the impact on quality of life: a survey in secondary care
- 1 July 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 69, 298-303
Prevalence of sleep disturbances in people with epilepsy and the impact on quality of life: a survey in secondary care
- Open Access
- 1 April 2019
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 62 (4) , 265-269
PRRT2-related phenotypes in patients with a 16p11.2 deletion
- 1 April 2019
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 62 (4) , 265-269
Open AccessPRRT2-related phenotypes in patients with a 16p11.2 deletion
- Open Access
- 12 December 2018
- Published by Oxford University Press (OUP) in Brain
- Vol. 142 (1) , 80-92
GRIN2A-related disorders: genotype and functional consequence predict phenotype
Alterations of the N-methyl-d-aspartate receptor (NMDAR) subunit GluN2A, encoded by GRIN2A, have been associated with a spectrum of neurodevelopmental disorders with prominent speech-related features, and epilepsy. We performed a comprehensive assessment of phenotypes with a standardized questionnaire in 92 previously unreported individuals with GRIN2A-related disorders. Applying the criteria of the American College of Medical Genetics and Genomics to all published variants yielded 156 additional cases with pathogenic or likely pathogenic variants in GRIN2A, resulting in a total of 248 individuals. The phenotypic spectrum ranged from normal or near-normal development with mild epilepsy and speech delay/apraxia to severe developmental and epileptic encephalopathy, often within the epilepsy-aphasia spectrum. We found that pathogenic missense variants in transmembrane and linker domains (misTMD+Linker) were associated with severe developmental phenotypes, whereas missense variants within amino terminal or ligand-binding domains (misATD+LBD) and null variants led to less severe developmental phenotypes, which we confirmed in a discovery (P = 10−6) as well as validation cohort (P = 0.0003). Other phenotypes such as MRI abnormalities and epilepsy types were also significantly different between the two groups. Notably, this was paralleled by electrophysiology data, where misTMD+Linker predominantly led to NMDAR gain-of-function, while misATD+LBD exclusively caused NMDAR loss-of-function. With respect to null variants, we show that Grin2a+/− cortical rat neurons also had reduced NMDAR function and there was no evidence of previously postulated compensatory overexpression of GluN2B. We demonstrate that null variants and misATD+LBD of GRIN2A do not only share the same clinical spectrum (i.e. milder phenotypes), but also result in similar electrophysiological consequences (loss-of-function) opposing those of misTMD+Linker (severe phenotypes; predominantly gain-of-function). This new pathomechanistic model may ultimately help in predicting phenotype severity as well as eligibility for potential precision medicine approaches in GRIN2A-related disorders.
- 12 December 2018
- Published by Oxford University Press (OUP) in Brain
- Vol. 142 (1) , 80-92
Open AccessGRIN2A-related disorders: genotype and functional consequence predict phenotype
Alterations of the N-methyl-d-aspartate receptor (NMDAR) subunit GluN2A, encoded by GRIN2A, have been associated with a spectrum of neurodevelopmental disorders with prominent speech-related features, and epilepsy. We performed a comprehensive assessment of phenotypes with a standardized questionnaire in 92 previously unreported individuals with GRIN2A-related disorders. Applying the criteria of the American College of Medical Genetics and Genomics to all published variants yielded 156 additional cases with pathogenic or likely pathogenic variants in GRIN2A, resulting in a total of 248 individuals. The phenotypic spectrum ranged from normal or near-normal development with mild epilepsy and speech delay/apraxia to severe developmental and epileptic encephalopathy, often within the epilepsy-aphasia spectrum. We found that pathogenic missense variants in transmembrane and linker domains (misTMD+Linker) were associated with severe developmental phenotypes, whereas missense variants within amino terminal or ligand-binding domains (misATD+LBD) and null variants led to less severe developmental phenotypes, which we confirmed in a discovery (P = 10−6) as well as validation cohort (P = 0.0003). Other phenotypes such as MRI abnormalities and epilepsy types were also significantly different between the two groups. Notably, this was paralleled by electrophysiology data, where misTMD+Linker predominantly led to NMDAR gain-of-function, while misATD+LBD exclusively caused NMDAR loss-of-function. With respect to null variants, we show that Grin2a+/− cortical rat neurons also had reduced NMDAR function and there was no evidence of previously postulated compensatory overexpression of GluN2B. We demonstrate that null variants and misATD+LBD of GRIN2A do not only share the same clinical spectrum (i.e. milder phenotypes), but also result in similar electrophysiological consequences (loss-of-function) opposing those of misTMD+Linker (severe phenotypes; predominantly gain-of-function). This new pathomechanistic model may ultimately help in predicting phenotype severity as well as eligibility for potential precision medicine approaches in GRIN2A-related disorders.
- 23 July 2018
- Published by Elsevier in Epilepsy Research
- Vol. 146, 21-27
Antiepileptic drug prescription in Dutch children from 2006–2014 using pharmacy-dispensing data
- 23 July 2018
- Published by Elsevier in Epilepsy Research
- Vol. 146, 21-27
Antiepileptic drug prescription in Dutch children from 2006–2014 using pharmacy-dispensing data
- 1 July 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (7) , 675.e1-675.e7
Perception of radiology reporting efficacy by neurologists in general and university hospitals
- 1 July 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (7) , 675.e1-675.e7
Perception of radiology reporting efficacy by neurologists in general and university hospitals
- 20 April 2018
- Published by Springer Nature in European Radiology
- Vol. 28 (10) , 4274-4280
Improvement of radiology reporting in a clinical cancer network: impact of an optimised multidisciplinary workflow
To assess the effectiveness of implementing a quality improvement project in a clinical cancer network directed at the response assessment of oncology patients according to RECIST-criteria.
- 20 April 2018
- Published by Springer Nature in European Radiology
- Vol. 28 (10) , 4274-4280
Improvement of radiology reporting in a clinical cancer network: impact of an optimised multidisciplinary workflow
To assess the effectiveness of implementing a quality improvement project in a clinical cancer network directed at the response assessment of oncology patients according to RECIST-criteria.
- Open Access
- 1 January 2018
- Published by SAGE Publications in Child Neurology Open
- Vol. 5
Ketogenic Diet in Refractory Childhood Epilepsy
Background: Ketogenic diet in children with epilepsy has a considerable impact on daily life and is usually adopted for at least 3 months. Our aim was to evaluate whether the introduction of an all-liquid ketogenic diet in an outpatient setting is feasible, and if an earlier assessment of its efficacy can be achieved. Methods: The authors conducted a prospective, observational study in a consecutive group of children with refractory epilepsy aged 2 to 14 years indicated for ketogenic diet. Ketogenic diet was started as an all-liquid formulation of the classical ketogenic diet, KetoCal 4:1 LQ, taken orally or by tube. After 6 weeks, the liquid diet was converted into solid meals. The primary outcome parameter was time-to-response (>50% seizure reduction). Secondary outcome parameters were time to achieve stable ketosis, the number of children showing a positive response, and the retention rate at 26 weeks. Results: Sixteen children were included. Four of them responded well with respect to seizure frequency, the median time-to-response was 14 days (range 7-28 days). The mean time to achieve stable ketosis was 7 days. The retention rate at 26 weeks was 50%. Of the 8 children who started this protocol orally fed, 6 completed it without requiring a nasogastric tube. Conclusions: Introduction of ketogenic diet with a liquid formulation can be accomplished in orally fed children without major complications. It allowed for fast and stable ketosis.
- 1 January 2018
- Published by SAGE Publications in Child Neurology Open
- Vol. 5
Open AccessKetogenic Diet in Refractory Childhood Epilepsy
Background: Ketogenic diet in children with epilepsy has a considerable impact on daily life and is usually adopted for at least 3 months. Our aim was to evaluate whether the introduction of an all-liquid ketogenic diet in an outpatient setting is feasible, and if an earlier assessment of its efficacy can be achieved. Methods: The authors conducted a prospective, observational study in a consecutive group of children with refractory epilepsy aged 2 to 14 years indicated for ketogenic diet. Ketogenic diet was started as an all-liquid formulation of the classical ketogenic diet, KetoCal 4:1 LQ, taken orally or by tube. After 6 weeks, the liquid diet was converted into solid meals. The primary outcome parameter was time-to-response (>50% seizure reduction). Secondary outcome parameters were time to achieve stable ketosis, the number of children showing a positive response, and the retention rate at 26 weeks. Results: Sixteen children were included. Four of them responded well with respect to seizure frequency, the median time-to-response was 14 days (range 7-28 days). The mean time to achieve stable ketosis was 7 days. The retention rate at 26 weeks was 50%. Of the 8 children who started this protocol orally fed, 6 completed it without requiring a nasogastric tube. Conclusions: Introduction of ketogenic diet with a liquid formulation can be accomplished in orally fed children without major complications. It allowed for fast and stable ketosis.